Related Experiment Video

Updated: Jul 13, 2026

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
12:02

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

Cerebral ischemia, cell cycle elements and Cdk5

Serge Timsit1, Bénédicte Menn

  • 1Faculté de Médecine et des Sciences de la Santé de Brest, Brest, France. serge.timsit@chu-brest.fr

Biotechnology Journal
|July 10, 2007
PubMed

Insights

New research links cell cycle proteins, like cyclins and cyclin-dependent kinases (Cdks), to neuronal death after stroke. Cdk inhibitors show promise as a neuroprotective therapy for ischemic stroke brain injury.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Neurology

Background:

  • Stroke is a leading cause of death and disability, driving significant healthcare costs.
  • Current research focuses on neuroprotective agents to prevent neuronal death and brain damage.
  • Cell cycle regulatory proteins are increasingly implicated in neuronal death following ischemic events.

Purpose of the Study:

  • To review evidence linking cell cycle molecules to ischemic neuronal death.
  • To evaluate cyclin-dependent kinase (Cdk) inhibitors as a potential neuroprotective strategy.

Main Methods:

  • In vitro studies examining the role of cell cycle proteins in neuronal death.
  • In vivo studies investigating the effects of ischemic insult on neuronal cell cycle regulation.
  • Evaluation of Cdk inhibitors for neuroprotective potential.

Main Results:

  • Cell cycle molecules, including cyclins, mitotic Cdks, and Cdk5, are linked to ischemic neuronal death.
  • Evidence supports the involvement of these proteins in the mechanisms of brain damage after stroke.
  • Cdk inhibitors demonstrate potential as a therapeutic approach.

Conclusions:

  • Cell cycle regulation plays a critical role in neuronal survival after ischemic stroke.
  • Targeting cell cycle proteins, particularly with Cdk inhibitors, offers a promising neuroprotective strategy for stroke treatment.

More Related Videos

Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk113:15

Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1

Published on: February 25, 2016

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...